APA (7th ed.) Citation

JC, W., SC, S., KA, N., CL, F., MR, M., VM, Y., & PH, W. (1980). Potential of mezlocillin as empiric single-agent therapy in febrile granulocytopenic cancer patients. Antimicrobial agents and chemotherapy, 18(2), 299. https://doi.org/10.1128/AAC.18.2.299

Chicago Style (17th ed.) Citation

JC, Wade, Schimpff SC, Newman KA, Fortner CL, Moody MR, Young VM, and Wiernik PH. "Potential of Mezlocillin as Empiric Single-agent Therapy in Febrile Granulocytopenic Cancer Patients." Antimicrobial Agents and Chemotherapy 18, no. 2 (1980): 299. https://doi.org/10.1128/AAC.18.2.299.

MLA (9th ed.) Citation

JC, Wade, et al. "Potential of Mezlocillin as Empiric Single-agent Therapy in Febrile Granulocytopenic Cancer Patients." Antimicrobial Agents and Chemotherapy, vol. 18, no. 2, 1980, p. 299, https://doi.org/10.1128/AAC.18.2.299.